Overview


According to FutureWise analysis the market for Animal Antibiotics and Antimicrobials in 2023 is US$ 4.9 billion, and is expected to reach US$ 6.87 billion by 2031 at a CAGR of 4.30%.

Animal antibiotics are specialized medications used to treat bacterial infections in animals. They are similar to antibiotics used in humans but are specifically formulated and approved for use in veterinary medicine. They may function by eliminating the bacteria (bactericidal) or inhibiting their growth and reproduction of bacteria (bacteriostatic), allowing the animal's immune system to fight a bacterial infection more effectively. In either case, the bottom line is that an antibiotic treatment suppresses the growth of a bacterial infection so the host (i.e., the animal) can eliminate it. The animal can then heal and return to health. These medications can be administered to various types of animals, including livestock (such as cows, pigs, and chickens), pets (such as dogs and cats), and even exotic animals.

The consistent usage of antibiotics (e.g., prescribed for therapy, misused, or overused) creates a selective pressure on pathogenic bacteria but also on commensal bacteria (e.g., gut or skin microbiota) that can determine the prevalence of antibiotic-resistant bacteria (ARBs) and the spread of resistant bacteria or genes. Plasmids, bacteriophages, or integrative mobile genetic elements facilitate horizontal gene transfer; thus, it is essential to reduce and limit the use of antibiotics by following the "principles of responsible and prudent use" to preserve their effectiveness.

FutureWise Market Research has published a report that provides an insightful analysis Animal Antibiotics and Antimicrobials Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, Animal Antibiotics and Antimicrobials Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Boehringer Ingelheim
  • Zoetis Inc.
  • Elanco Animal Health
  • MerckCo. Inc.
  • Phibro Animal Health
  • Virbac
  • Vetoquinol SA
  • HIPRA
  • Ceva Santé Animale
  • Dechra Pharmaceuticals Plc
  • Kyoritsu Seiyaku
  • Tianjin Ringpu
  • China Animal Husbandry
  • Endovac Animal Health
  • Zydus
  • Indian Immunologicals Pvt. Ltd.
  • UCBVET
  • American Reagent Inc.
  • Neogen Corporation
  • Huvepharma Inc.
  • Ayurvet
  • Ashish Life Science
  • Inovet
  • Lutim Pharma
  • ECO Animal Health (US)

(Note: The list of the major players will be updated with the latest market scenario and trends)
 

Recent Developments in Animal Antibiotics and Antimicrobials Market:

  • In May 2023, Bayer AG announced the launch of a new antibiotic called Ceftiofur. This third-generation cephalosporin is used to treat various animal infections, including respiratory infections, urinary infections, and skin infections.
  • In April 2023, Elanco Animal Health announced the launch of a new antibiotic called draxin. Draxxin is a once-daily, injectable antibiotic that is used to treat serious diseases caused by gram-negative bacteria, such as Klebsiella, E. coli, and pneumonia.

The increasing prevalence of global demand for animal-based protein sources to meet nutritional needs, driven by population growth and changing dietary preferences, has generated a compelling need for enhanced livestock health and disease management and is expected to drive market growth. This rise in demand places significant stress on the livestock industry to maintain healthy and productive animal populations. To accomplish this, antibiotics and antimicrobials become essential tools for preventing and treating diseases within these livestock populations. These pharmaceuticals safeguard animal health and provide a sustainable and reliable supply of protein, addressing a fundamental requirement in a world marked by a growing need for nourishment, further propelling the market growth. Furthermore, the development of alternative products like probiotics, vaccines, and phytogenics presents a favorable opportunity for the animal antibiotics and antimicrobials market. These innovative approaches offer sustainable and environmentally friendly practices for maintaining animal health and productivity. Probiotics encourage beneficial microbial populations in the digestive system, improving immunity and disease resistance. Vaccines provide targeted protection against specific diseases, lowering the need for broad-spectrum antibiotics. Phytogenics, derived from plants, offer natural antimicrobial properties. Adopting these alternatives addresses concerns over antimicrobial resistance and coincides with a growing consumer choice for more natural approaches in animal agriculture. However, the concern over the widespread use of antibiotic and antifungal drugs is the rise of antimicrobial resistance (AMR). As these medications are essential in saving lives by fighting infections, their overuse and misuse have accelerated the growth of resistant germs. This poses a serious threat as AMR may spread across different related domains, including humans, animals, and the environment. Also, the spreading of resistant pathogens, not only among individuals but also through water and soil contamination, limits the efficacy of existing treatments, making it challenging to manage infections and necessitating the development of new drugs. Therefore, hindering the market growth over the forecast period.

By Type of Product

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Lincosamides
  • Fluoroquinolones
  • Cephalosporins
  • Other Antimicrobials and Antibiotics

By Mode of Delivery

  • Premixes
  • Oral Powder
  • Oral Solution
  • Injection
  • Others

By Animal Type

  • Food-Producing Animals
    • Cattle
    • Pigs
    • Poultry
    • Sheep and Goats
    • Other Food-producing Animals
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to factors including rising incidences of zoonotic disease, growing demand for animal-derived food products, implementation of regulations to prevent the spread of animal diseases, rising animal healthcare spending, growth in pet insurance, high companion animal ownership, the need to increase the productivity of livestock, excessive consumption of livestock products, well-established animal agriculture industry, presence of market players, advanced veterinary healthcare infrastructure is anticipated to fuel the market expansion over the projection period. For instance, according to a React report, India is the world’s 5th largest meat producer. India largely consumes chicken as the most popular type of meat. Therefore, an increase in the usage of antimicrobials and antibiotics in chicken is expected to drive market growth in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Animal Antibiotics and Antimicrobials Market By Type of Product, By Mode of Delivery, By Animal Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Antibiotics and Antimicrobials Market Variables, Trends & Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Antibiotics and Antimicrobials Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Antibiotics and Antimicrobials Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Antibiotics and Antimicrobials Market, By Type of Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Tetracyclines
        2. Penicillins
        3. Sulfonamides
        4. Macrolides
        5. Aminoglycosides
        6. Lincosamides
        7. Fluoroquinolones
        8. Cephalosporins
        9. Other Antimicrobials and Antibiotics

  • 8.   Animal Antibiotics and Antimicrobials Market, By Mode of Delivery Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Premixes
        2. Oral Powder
        3. Oral Solution
        4. Injection
        5. Others

  • 9.   Animal Antibiotics and Antimicrobials Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Food-Producing Animals
         1.1. Cattle
         1.2. Pigs
         1.3. Poultry
         1.4. Sheep and Goats
         1.5. Other Food-producing Animals
        2. Companion Animals
         2.1. Dogs
         2.2. Cats
         2.3. Horses
         2.4. Other Companion Animals

  • 10.   North America Animal Antibiotics and Antimicrobials Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Animal Antibiotics and Antimicrobials Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Animal Antibiotics and Antimicrobials Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Animal Antibiotics and Antimicrobials Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •       1. Boehringer Ingelheim
             1.1. Company Overview
             1.2. Product Portfolio
             1.3. SWOT Analysis
             1.4. Financial Overview
             1.5. Strategic Overview
            2. Zoetis Inc.
             2.1. Company Overview
             2.2. Product Portfolio
             2.3. SWOT Analysis
             2.4. Financial Overview
             2.5. Strategic Overview
            3. Elanco Animal Health
             3.1. Company Overview
             3.2. Product Portfolio
             3.3. SWOT Analysis
             3.4. Financial Overview
             3.5. Strategic Overview
            4. MerckCo. Inc.
             4.1. Company Overview
             4.2. Product Portfolio
             4.3. SWOT Analysis
             4.4. Financial Overview
             4.5. Strategic Overview
            5. Phibro Animal Health
             5.1. Company Overview
             5.2. Product Portfolio
             5.3. SWOT Analysis
             5.4. Financial Overview
             5.5. Strategic Overview
            6. Virbac
             6.1. Company Overview
             6.2. Product Portfolio
             6.3. SWOT Analysis
             6.4. Financial Overview
             6.5. Strategic Overview
            7. Vetoquinol SA
             7.1. Company Overview
             7.2. Product Portfolio
             7.3. SWOT Analysis
             7.4. Financial Overview
             7.5. Strategic Overview
            8. HIPRA
             8.1. Company Overview
             8.2. Product Portfolio
             8.3. SWOT Analysis
             8.4. Financial Overview
             8.5. Strategic Overview
            9. Ceva Santé Animale
             9.1. Company Overview
             9.2. Product Portfolio
             9.3. SWOT Analysis
             9.4. Financial Overview
             9.5. Strategic Overview
            10.Dechra Pharmaceuticals Plc
             10.1. Company Overview
             10.2. Product Portfolio
             10.3. SWOT Analysis
             10.4. Financial Overview
             10.5. Strategic Overview
            11.Kyoritsu Seiyaku
             11.1. Company Overview
             11.2. Product Portfolio
             11.3. SWOT Analysis
             11.4. Financial Overview
             11.5. Strategic Overview
            12.Tianjin Ringpu
             12.1. Company Overview
             12.2. Product Portfolio
             12.3. SWOT Analysis
             12.4. Financial Overview
             12.5. Strategic Overview
            13.China Animal Husbandry
             13.1. Company Overview
             13.2. Product Portfolio
             13.3. SWOT Analysis
             13.4. Financial Overview
             13.5. Strategic Overview
            14.Endovac Animal Health
             14.1. Company Overview
             14.2. Product Portfolio
             14.3. SWOT Analysis
             14.4. Financial Overview
             14.5. Strategic Overview
            15.Zydus
             15.1. Company Overview
             15.2. Product Portfolio
             15.3. SWOT Analysis
             15.4. Financial Overview
             15.5. Strategic Overview
            16.Indian Immunologicals Pvt. Ltd.
             16.1. Company Overview
             16.2. Product Portfolio
             16.3. SWOT Analysis
             16.4. Financial Overview
             16.5. Strategic Overview
            17.UCBVET
             17.1. Company Overview
             17.2. Product Portfolio
             17.3. SWOT Analysis
             17.4. Financial Overview
             17.5. Strategic Overview
            18.American Reagent Inc.
             18.1. Company Overview
             18.2. Product Portfolio
             18.3. SWOT Analysis
             18.4. Financial Overview
             18.5. Strategic Overview
            19.Neogen Corporation
             19.1. Company Overview
             19.2. Product Portfolio
             19.3. SWOT Analysis
             19.4. Financial Overview
             19.5. Strategic Overview
            20.Huvepharma Inc.
             20.1. Company Overview
             20.2. Product Portfolio
             20.3. SWOT Analysis
             20.4. Financial Overview
             20.5. Strategic Overview
            21.Ayurvet
             21.1. Company Overview
             21.2. Product Portfolio
             21.3. SWOT Analysis
             21.4. Financial Overview
             21.5. Strategic Overview
            22.Ashish Life Science
             22.1. Company Overview
             22.2. Product Portfolio
             22.3. SWOT Analysis
             22.4. Financial Overview
             22.5. Strategic Overview
            23.Inovet
             23.1. Company Overview
             23.2. Product Portfolio
             23.3. SWOT Analysis
             23.4. Financial Overview
             23.5. Strategic Overview
            24.Lutim Pharma
             24.1. Company Overview
             24.2. Product Portfolio
             24.3. SWOT Analysis
             24.4. Financial Overview
             24.5. Strategic Overview
            25.ECO Animal Health
             25.1. Company Overview
             25.2. Product Portfolio
             25.3. SWOT Analysis
             25.4. Financial Overview
             25.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients